Similarly, in the AT-3 mammary carcinoma cell line, the multipotent, chemoresistant CSC–like population demonstrates higher levels of FAS and DR5 compared to non–CSC–like cells, correlating with increased apoptosis sensitivity induced by the FAS ligand and TRAIL [36]. This evidence concerns the gene FAS and breast carcinoma.